Skip to main content
Patrick Nachman, MD, Nephrology, Minneapolis, MN

Patrick H Nachman MD FASN

Glomerular Disease


Professor, Medicine, University of Minnesota. Director, Division of Renal Diseases and Hypertension. Director, Minnesota Multidisciplinary Vasculitis Program

Join to View Full Profile
  • Division of Nephrology and Hypertension717 Delaware St. SEMinneapolis, MN 55414

  • Phone+1 612-624-9444

Dr. Nachman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Nephrology, 1992 - 1996
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1989 - 1992
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1989

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2017 - 2027
  • NC State Medical License
    NC State Medical License 1991 - 2027
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Fellow (FASN) American Society of Nephrology
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Case Studies in Glomerular Disease 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

  • Repeat Kidney Biopsy for Lupus Nephritis: An Important Step ForwardSeptember 2018

Press Mentions

  • FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Control
    FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus ControlNovember 17th, 2022
  • U of M Awarded $2.5M in NIH Funding for Minnesota Site of Kidney Precision Medicine Project
    U of M Awarded $2.5M in NIH Funding for Minnesota Site of Kidney Precision Medicine ProjectNovember 3rd, 2022
  • Sickle Cell Trait Is Not Risk Factor for Kidney Disease: Study Contradicts Earlier Findings
    Sickle Cell Trait Is Not Risk Factor for Kidney Disease: Study Contradicts Earlier FindingsSeptember 14th, 2011

Grant Support

  • Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & EthicsUNIVERSITY OF MINNESOTA2022–2027
  • Clinical Trial: Rituximab In The Treatment Of Idiopathic Membranous NephropathyNational Center For Research Resources2008
  • Cyclophosphamide-Related Urothelial Tumor EvaluationNational Center For Research Resources2004
  • Anti-Myeloperoxidase Autoantibody ResponseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Study To Evaluate The Renal Protective Effects Of LosartanNational Center For Research Resources1998–2002

Committees

  • Board member, Kidney Health Initial 2020 - Present
  • Chair, American Society of Nephrology. Post Graduate Education Committee 2015 - 2018
  • Member, American Society of Nephrology Post Graduate Education Committee 2009 - 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: